HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Health Catalyst, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.71−0.02 (-0.87%)
Close on Oct 19, 2026
- Market cap
- $126.47M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.34 (−43.93%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Health Catalyst, Inc. saw revenue fall 7.5% to $292.25M over the twelve months to Jun 30, 2026. Free cash flow was $27.02M.
Revenue
$292.25M
-7.5% vs. a year earlier
Operating income
-$246.55M
TTM Q2 2026
Free cash flow
$27.02M
TTM Q2 2026
EPS, diluted
-$3.68
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $126.47M
- P/E ratio
- –
- Price to sales
- 0.43
- Price to book
- 1.25
- Dividend yield
- –
- Free cash flow yield
- 21.37%
Fundamentals
- Revenue
- $292.25M
- Net income
- -$264.82M
- EPS, diluted
- -$3.68
- Free cash flow
- $27.02M
- Book value per share
- $1.36
- Diluted shares
- 74M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
$292.25M-7.5% YoY
Gross profit
$149.84M+3.0% YoY
Operating income
-$246.55M
Net income
-$264.82M
EPS, diluted
-$3.68
Free cash flow
$27.02M
Reported periodTrailing twelve months